资源描述：
《颅内压监护在重型颅脑外伤中的作用》由会员上传分享，免费在线阅读，更多相关内容在行业资料-天天文库。
1、Abstractpatientswithintracranialpressureincraniocerebralsurgeryafter12hoursbegantoappearslightlyelevatedICPin15~20mmHg)after48hoursappeararoundthepeak,mostofthepatientsin20~30mmHgfluctuations,thepeakappearedinthe3-5days,thefluctuationofICPvaluein25~30mmHg,so
2、mepatientsICPreached35to40mmHg,thepartofthepatientprognosisisgood,partofthepatientsafter1to4hoursofintracranialpressureincreasesashighas30to40mmHg,suggestingthatmayberequiredreoperationtreatment.3.ICPgroupwasfoundin7casesrequiredreoperationforpatients,thetim
3、efor2.2±0.8(H)andconventionalgroupfoundthatneededtosurgerypatientsin8cases,thetimefor3.4±1.1(H),aftersurgery,theICPgroupinGlasgowOutcomeScore(GOS)lightdisabilityin2cases,severedisabilityin2cases,plantsurvivalin2cases,1casedied,conventionalgroup1hadseveredisa
4、bility,plantsurvivalin4cases,3casesdied,thetwogroupsofpatientsfoundagainoperativetimeandprognosiswerestatisticallysignificant(P<0.05).4.ICPgroupthedosageofmannitolfor951.0±325.4(g),complicatedwithacuterenalfunctionnotall3cases(10%),thedosageofmannitolinthero
5、utinegroupfor1260.0±635.7(g),complicatedwithacuterenalfunctionisnotallofthe10cases(33.3%),respectively,werestatisticallyanalyzedandwerestatisticallysignificant(P<0.05).5.ICPgroupoccurredintracranialinfectionin1case(3.3%),thecabletravelaroundnewhemorrhagecase
6、s(0%)androutinegroupoccurredintracranialinfectionin2cases(6.7%),comparedwithnostatisticalsignificance(P>0.05).Conclusion:1.ApplicationofICPmonitoringcanimprovetheprognosisofpatientswithreh-abilitationinpatientswithseverecraniocerebralinjury.2.Within7daysafte
7、rtheoperationofseverecraniocerebralinjury,intracranialpressurechangesexistcertainregularity,fromchangestoassessmentofpatient'sconditionandprognosisofrehabilitation.3.Inthechangesofthedisease,theICPgroupfoundthatthetimeofreoperationwassignificantlyadvanced,an
8、dearlysurgicaltreatmentcouldimprovetheprognosisofthepatients.4.Intheapplicationofintracranialpressuremonitoring,canreducethedosageofmannitolandreducethecomplicationsofacuterenalinsufficiency.5.I
